Clinical trials
Fabry Disease trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
14 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2001 | 1 |
| 2010 | 1 |
| 2021 | 2 |
| 2022 | 3 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 5 |
| Unknown status | 3 |
| Active, not recruiting | 2 |
| Completed | 2 |
| Not yet recruiting | 1 |
| Withdrawn | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Children's Hospital of Fudan University | 2 |
| Genzyme, a Sanofi Company | 2 |
| Sanofi | 2 |
| Takeda | 2 |
| AceLink Therapeutics, Inc. | 1 |
| Chinese Academy of Medical Sciences, Fuwai Hospital | 1 |
| First Hospital of China Medical University | 1 |
| Guangzhou Jiayin Biotech Ltd | 1 |
| Qilu Hospital of Shandong University | 1 |
| The Children's Hospital of Zhejiang University School of Medicine | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Fabry Disease | 14 |
| Amyloid Neuropathies, Familial | 2 |
| Cardiomyopathy, Hypertrophic | 2 |
| Hypertrophy, Left Ventricular | 2 |
| Angiokeratoma | 1 |
| Cardiomyopathies | 1 |
| Disease | 1 |
| Glycogen Storage Disease | 1 |
| Glycogen Storage Disease Type IIb | 1 |
| Noonan Syndrome | 1 |
Trials
Showing 76 to 14 of 14. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.